{"id":14653,"date":"2020-09-11T08:47:05","date_gmt":"2020-09-11T12:47:05","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=14653"},"modified":"2020-09-11T08:47:05","modified_gmt":"2020-09-11T12:47:05","slug":"new-filings-updated-terms-week-ending-09-11-20am","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-week-ending-09-11-20am\/","title":{"rendered":"New Filings & Updated Terms — Week Ending 09.11.20(AM)"},"content":{"rendered":"

NEW FILINGS<\/strong><\/span><\/p>\n

Company: Pulmonx Corporation
\nSymbol: LUNG
\nDescription: They are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Securities, Morgan Stanley
\nCo-Manager: Stifel, Wells Fargo Securities, Canaccord Genuity
\nFiled:9-4-20
\nListed Cash Raise: $86.25m<\/p>\n

Company: Prelude Therapeutics Incorporated
\nSymbol: PRLD
\nDescription: They are a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, BofA Securities
\nFiled:9-4-20
\nListed Cash Raise: $100m<\/p>\n

Company: PMV Pharmaceuticals, Inc
\nSymbol: PMVP
\nDescription: They are a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 is a well-defined tumor suppressor protein known as the \u201cguardian of the genome,\u201d and normal, or wild-type, p53 has the ability to eliminate cancer cells.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, BofA Securities, Cowen, Evercore ISI
\nFiled:9-4-20
\nListed Cash Raise: $100m<\/p>\n

Company: Graybug Vision, Inc.
\nSymbol: GRAY
\nDescription: They are a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): SVB Leerink, Piper Sandler
\nCo-Manager: Needham, Wedbush PacGrow
\nFiled:9-4-20
\nListed Cash Raise: $86.25m<\/p>\n

Company: Orphazyme A\/S
\nSymbol: ORPH
\nDescription: They are a late-stage biopharmaceutical company harnessing the amplification of Heat Shock Proteins, or HSPs, in order to develop and commercialize novel therapeutics for the treatment of neurodegenerative orphan diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Securities, Cowen, Guggenheim
\nCo-Manager: Danske Markets
\nFiled:9-4-20
\nListed Cash Raise: $115m<\/p>\n

Company: VIA optronics AG
\nSymbol: VIAO
\nDescription: They are a leading provider of enhanced display solutions for multiple end-markets in which superior functionality or durability is a critical differentiating factor.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Berenberg
\nFiled:9-4-20
\nListed Cash Raise: $100m<\/p>\n

Company: Mission Produce, Inc.
\nSymbol: AVO
\nDescription: They are a world leader in sourcing, producing and distributing fresh avocados, serving retail, wholesale and foodservice customers in over 25 countries.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Securities, J.P. Morgan, Citigroup
\nCo-Manager: Roth Capital Partners, Stephens Inc., D.A. Davidson & Co.
\nFiled:9-4-20
\nListed Cash Raise: $100m<\/p>\n

Company: Taysha Gene Therapies, Inc.
\nSymbol: TSHA
\nDescription: They are a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, Jefferies
\nCo-Manager: Chardan
\nFiled:9-2-20
\nListed Cash Raise: $100m<\/p>\n

Company: Boqii Holding Limited
\nSymbol: BQ
\nDescription: They are the largest pet-focused platform in China, in terms of revenue in 2019 and number of customers as of December 31, 2019, according to Frost & Sullivan.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s):Roth Capital Partners, CMBI, Valuable Capital Limited
\nFiled: 9-8-20
\nListed Cash Raise: $115m<\/p>\n

Company: Yalla Group Limited
\nSymbol: YALA
\nDescription: They are the largest voice-centric social networking and entertainment platform in MENA as measured by revenue in 2019, according to the Frost & Sullivan Report.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Haitong International
\nCo-Manager: Tiger Global
\nFiled: 9-8-20
\nListed Cash Raise: $100m<\/p>\n

Company: iHuman Inc.
\nSymbol: IH
\nDescription: They are a leading childhood edutainment company in China, with core expertise in providing integrated and innovative products and services catering to the education demands for children mainly aged between three and eight.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, Citigroup
\nCo-Manager: Tiger Brokers
\nFiled:9-8-20
\nListed Cash Raise: $100m<\/p>\n

Company: Chindata Group Holdings Limited
\nSymbol: CD
\nDescription: They are the leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets, focusing on the China, India and Southeast Asia markets.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Citigroup
\nCo-Manager: UBS Investment Bank, China Renaissance
\nFiled: 9-8-20
\nListed Cash Raise: $100m<\/p>\n

Company: GRAIL, Inc.
\nSymbol: GRAL
\nDescription: They are a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, BofA Securities, Cowen, Evercore ISI
\nFiled: 9-9-20
\nListed Cash Raise: $100m<\/p>\n

Company: Academy Sports and Outdoors, Inc.
\nSymbol: ASO
\nDescription: They are one of the leading full-line sporting goods and outdoor recreation retailers in the United States.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, J.P. Morgan, KKR, BofA Securities, Evercore ISI, Guggenheim Securities, UBS Investment Bank, Wells Fargo Securities
\nCo-Manager(s): Stephens Inc., Capital One Securities, Loop Capital Markets, CastleOak Securities, L.P. Blaylock Van, Cabrera Capital Markets, Ramirez & Co., R. Seelaus & Co.
\nFiled: 9-9-20
\nListed Cash Raise: $100m<\/p>\n

Company: Codiak BioSciences, Inc.
\nSymbol: CDAK
\nDescription: They are a development-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Evercore ISI, William Blair
\nCo-Manager: Wedbush PacGrow
\nFiled: 9-9-20
\nListed Cash Raise: $100m
\nNote: First Filed in April 2019<\/p>\n

Company: Lixiang Education Holding Co., Ltd.
\nSymbol: LXEH
\nDescription: They are a prominent private primary and secondary education service provider in Lishui City, Zhejiang Province.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): AMTD
\nCo-Manager: Loop Capital
\nFiled: 9-9-20
\nListed Cash Raise: $30m<\/p>\n

Company: C4 Therapeutics, Inc.
\nSymbol: CCCC
\nDescription: They are a biopharmaceutical company focused on harnessing the body\u2019s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Evercore ISI, BMO Capital Markets, UBS Investment Bank
\nFiled:9-10-20
\nListed Cash Raise: $100m<\/p>\n

TERMS ADDED<\/strong><\/span><\/p>\n

Company: Sumo Logic, Inc.
\nSymbol: SUMO
\nDescription: Sumo Logic is the pioneer of Continuous Intelligence, a new category of software, which enables organizations of all sizes to address the challenges and opportunities presented by digital transformation, modern applications, and cloud computing.
\nShares: 14.8 million
\nPrice Range: $17.00-$21.00
\nMarket Cap: $1.68b-$2.07b
\nTrade Date: Thursday, 9\/17
\nUnderwriter(s): Morgan Stanley, JP Morgan, RBC Capital Markets, Jefferies
\nCo-Manager(s): William Blair, Cowen, Piper Sandler, BTIG
\nFiled: 8-24-20
\nTerms Added: 9-8-20<\/p>\n

Company: Pactiv Evergreen Inc
\nSymbol: PTVE
\nDescription: They are the largest manufacturer and distributor of fresh foodservice and food merchandising products and fresh beverage cartons in North America (as measured by revenue).
\nShares: 41.0 million
\nPrice Range: $18.00-$21.00
\nMarket Cap:$3.16b-$3.68b
\nTrade Date: Thursday, 9\/17
\nUnderwriter(s): Credit Suisse, Citigroup, BofA Securities, Goldman Sachs
\nCo Managers: Baird, BMO Capital, Deutsche Bank, RBC Capital, HSBC, Academy Securities, Loop Capital, Rabo Securities, Ramirez & Co., Siebert Williams Shank
\nFiled: 8-24-20
\nTerms Added: 9-8-20<\/p>\n

Company: Snowflake Inc.
\nSymbol: SNOW
\nDescription: They believe in a data connected world where organizations have seamless access to explore, share, and unlock the value of data. To realize this vision, they are pioneering the Data Cloud, an ecosystem where Snowflake customers, partners, and data providers can break down data silos and derive value from rapidly growing data sets in secure, governed, and compliant ways.
\nShares: 28 million
\nPrice Range: $75.00-$85.00
\nTrade Date: Wednesday, 9\/16
\nMarket Cap: $20.9bn-$$23.7bn
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, JP Morgan, Allen & Co., Citigroup, Credit Suisse, Barclays, Deutsche Bank, Mizuho Securities, Trust Securities
\nCo-Manager(s): BTIG, Canaccord Genuity, Capital One Securities, Cowen, DA Davidson, JMP Securities, Oppenheimer, Piper Sandler, Stifel, Academy Securities, Loop Capital, Ramirez & Co., Siebert Williams Shank
\nTerms Added: 9-8-20<\/p>\n

Company: Vitru Limited
\nSymbol: VTRU
\nDescription: They are the leading pure distance learning education group in the postsecondary digital education market in Brazil.
\nShares: 11,230,126 million
\nPrice Range: $22.00-$24.00
\nMarket Cap: $507m-$553m
\nTrade Date: Thursday, 9\/17
\nUnderwriter(s): Goldman Sachs, BofA Securities, Itau BBA, Morgan Stanley, Bradesco BBI, BTG Pactual, Credit Suisse, Santander, XP Investimentos
\nFiled: 8-24-20
\nTerms Added: 9-8-20<\/p>\n

Company: JFrog Ltd.
\nSymbol: FROG
\nDescription: They provide an end-to-end, hybrid, universal DevOps Platform to achieve Continuous Software Release Management, or CSRM.
\nShares: 11,568,218 million
\nMarket Cap: $2.93b-$3.28b
\nTrade Date: Wednesday, 9\/16
\nUnderwriter(s): Morgan Stanley, J.P. Morgan, BofA Securities
\nCo-Manager(s): Keybanc Capital Markets, Piper Sandler, Stifel, William Blair, Oppenheimer & Co., Needham & Company
\nFiled: 8-24-20
\nTerms Added 9-8-20<\/p>\n

Company: Broadstone Net Lease Inc.
\nSymbol: BNL
\nDescription: They are an internally-managed REIT that acquires, owns, and manages primarily single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants.
\nShares: 33.5 million
\nPrice Range: $17.00-$19.00
\nMarket Cap: $2.4b-$2.7b
\nTrade Date: Thursday, 9\/17
\nUnderwriter(s): J.P. Morgan, Goldman Sachs, BMO Capital Markets, Morgan Stanley, Capital One Securities, Truist Securities
\nCo-Manager(s): Regions Securities, BTIG, KeyBanc Capital Markets Ramirez & Co., Inc.
\nTerms Added: 9-8-20<\/p>\n

Company: American Well Corporation
\nSymbol: AMWL
\nDescription: They are a leading telehealth company enabling digital delivery of care for healthcare\u2019s key stakeholders.
\nShares: 35 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $3.08b-$3.52b
\nTrade Date: Thursday 9\/17
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, Piper Sandler, UBS Investment Bank, Credit Suisse, Cowen, Berenberg
\nFiled: 9-8-20<\/p>\n

Company: Metacrine, Inc.
\nSymbol: MTCR
\nDescription: They are a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal, or GI, diseases.
\nShares: 6.54 million
\nPrice Range: $12.00-$14.00
\nMarket Cap: $311m-$363m
\nTrade Date: Wednesday, 9\/16
\nUnderwriter(s): Jefferies, Evercore ISI, RBC Capital Markets
\nCo-Manager(s): Canaccord Genuity
\nTerms Added: 9-9-20<\/p>\n

Company: Unity Software, Inc.
\nSymbol: U
\nDescription: They are the world\u2019s leading platform for creating and operating interactive, real-time 3D content.
\nShares: 25 million
\nPrice Range: $34.00-$42.00
\nMarket Cap: $9.0b-$11.1b
\nTrade Date: Friday, 9\/18
\nUnderwriter(s): Goldman Sachs, Credit Suisse, BofA Securities, Barclays, William Blair
\nCo-Manager(s): Oppenheimer, Piper Sandler, Stifel, Wedbush Securities, Academy Securities, Siebert Williams Shank
\nTerms Added: 9-9-20<\/p>\n

Company: Outset Medical, Inc.
\nSymbol: OM
\nDescription: They are a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.
\nShares: 7.6 million
\nPrice Range: $22.00-$24.00
\nMarket Cap: $871m-$950m
\nTrade Date: Wednesday 9\/16
\nUnderwriter(s): BofA Securities, Morgan Stanley, Goldman Sachs, SVB Leerink, Stifel
\nTerms Added: 9-9-20<\/p>\n

Company: StepStone Group Inc.
\nSymbol: STEP
\nDescription: They are a global private markets investment firm focused on providing customized investment solutions and advisory and data services to our clients.
\nShares: 17.5 million
\nPrice Range: $15.00-$17.00
\nTrade Date: Wednesday, 9\/16
\nMarket Cap: $1.4b-$1.6b
\nUnderwriter(s): J.P. Morgan, Goldman Sachs, Morgan Stanley, Barclays, UBS Investment Bank
\nTerms Added: 9-9-20<\/p>\n

Company: Dyne Therapeutics Inc.
\nSymbol: DYN
\nDescription: They are building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases.
\nShares: 10.3 million
\nPrice Range: $16.00-$18.00
\nTrade Date: Thursday, 9\/17
\nMarket Cap: $667m-$750m
\nUnderwriter(s): J.P. Morgan, Jefferies, Piper Sandler, Stifel
\nTerms Added: 9-10-20<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-14653","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=14653"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14653\/revisions"}],"predecessor-version":[{"id":14654,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14653\/revisions\/14654"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=14653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=14653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=14653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}